TIDMPRM

RNS Number : 1630L

Proteome Sciences PLC

28 April 2020

28 April 2020

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Response to Share Price Movement

Proteome Sciences plc (AIM: PRM), notes the recent increase in the Company's share price and confirms that it is not aware of any material basis for this rise.

The Company refers shareholders to its Final Results announcement on 14 April 2020 and its Notice of Results announcement made on 30 March 2020.

For further information please contact:

 
 Proteome Sciences plc 
 Dr Ian Pike, Interim Chief Executive       Tel: +44 (0)20 7043 2116 
  Officer 
 Richard Dennis, Chief Commercial Officer 
 
 Allenby Capital Limited (AIM Nominated Adviser & Broker) 
 John Depasquale / Jeremy Porter            Tel: +44 (0) 20 3328 5656

About Proteome Sciences plc. ( www.proteomics.com )

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant(R) and TMT(R)MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator(TM) provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available.

The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

SPMEAELPAFSEEFA

(END) Dow Jones Newswires

April 28, 2020 06:16 ET (10:16 GMT)

Proteome Sciences (LSE:PRM)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Proteome Sciences.
Proteome Sciences (LSE:PRM)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Proteome Sciences.